Imaging: Staging and evaluation of lymphoma using nuclear medicine
- 28 February 2005
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 32, 11-18
- https://doi.org/10.1053/j.seminoncol.2005.01.009
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Nuclear OncologyPublished by Springer Nature ,2017
- Thallium-201 Imaging in Evaluation of Hodgkin??s DiseaseThe Cancer Journal, 2002
- Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- The continuing clinical role of gallium 67 scintigraphy in the age of receptor imagingSeminars in Nuclear Medicine, 1997
- The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patientsSeminars in Nuclear Medicine, 1995
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994
- Gallium 67 imaging in monitoring lymphoma response to treatmentCancer, 1988
- The role of transferrins in gallium uptakeInternational Journal of Nuclear Medicine and Biology, 1981
- Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphomaCancer, 1976